Antibiotic resistance of Streptococcus pneumoniae colonizing the nasopharynx of HIV-exposed Tanzanian infants.

Trop Med Int Health. 2015 Jul 30. doi: 10.1111/tmi.12582. [Epub ahead of print]

Antibiotic resistance of Streptococcus pneumoniae colonizing the nasopharynx of HIV-exposed Tanzanian infants.

Bles P1, de Mast Q2,3, van der Gaast-de Jongh CE1,2, Kinabo GD4, Kibiki G5, van de Ven A2,3, de Jonge MI1,2.

Author information

Abstract

OBJECTIVES:

To determine antibiotic susceptibility of colonizing pneumococcal serotypes in HIV-exposed infants before the introduction of the 13-valent Pneumococcal Conjugate Vaccine (PCV13), because HIV-exposed infants are at increased risk for invasive pneumococcal infections.

METHODS:

Antibiotic susceptibility of 104 pneumococcal isolates, cultured from the nasopharynx from Tanzanian HIV-exposed infants, was determined using the disk diffusion method and the E-test according to EUCAST version 4.0 (2014) criteria.

RESULTS:

69.2% of isolates were intermediately susceptible for benzyl penicillin (MIC 0.06 - 2 mg L-1); no high level resistance was found. All isolates but one were susceptible to ampicillin. Regarding non-beta-lactam antibiotics, 19.2% of isolates were resistant to doxycycline, 3.8% to erythromycin and 97.1% to trimethoprim/sulfamethoxazole. 15.4% of isolates were resistant to three antibiotic classes or more. There were no differences in antibiotic susceptibility between vaccine and non-vaccine serotypes. Reduced susceptibility of colonizing pneumococcal isolates for commonly used antibiotics is common in HIV-exposed Tanzanian infants.

CONCLUSIONS:

High dose penicillin and ampicillin remain appropriate first choices for non-meningeal pneumococcal infections in this group. This article is protected by copyright. All rights reserved.

This article is protected by copyright. All rights reserved.

KEYWORDS:

Streptococcus pneumoniae ; Colonization; HIV-exposed infants; Tanzania; antibiotic resistance

PMID: 26224321 [PubMed - as supplied by publisher]